Respiratory syncytial virus infection and congenital heart disease

References

• Robertson SE, Roca A, Alonso P, Simoes EA, Kartasasmita CB. Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. Bull Wld Hlth Org 2004; 82(12): 914–22
   Google Scholar
• Madhi SA, Kuwanda L, Cutland C, Klug man KR Five-year cohort study of hospitalization forrespiratory syncytial virus associated lower respiratory tract infection in African children. J Clin V/ro/2006; 36(3): 215–21
   Google Scholar
• Vardas E, Blaauw D, McAnerney J. The epidemiology of respiratory syncytial virus (RSV) infections in South African children. S Afr Med J1999; 89(10): 1079–1084
   Google Scholar
• Madhi SA, Schoub B, Sim mank K, Blackburn N, Klugman KR Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr 2000; 137(1): 78–84
   Google Scholar
• MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982; 307(7): 397–400
   Google Scholar
• Navas L, Wang E, De Carvalho V, Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 1992; 121(3): 348–354
   Google Scholar
• Moler FW, Khan AS, Meliones JN, Custer JR, Palm isano J, Shope TG. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit Care Med 1992; 20(10): 1406–1413
   Google Scholar
• Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995; 126(2): 212–219
   Google Scholar
• Simoes EA, Sondheimer HM, Top FH Jr, et al. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group. J Pediatr 1998; 133(4): 492–499
   Google Scholar
• Feltes TF, Cabalka AK, Meissner HC, et al, Cardiac Synagis Study Group. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003; 143(4): 532–540
   Google Scholar
• Cabalka AK. Physiologic risk factors for respiratory viral infections and immunoprophylaxis or respiratory syncytial virus in young children with congenital heart disease. Pediatr Infect Dis J 2004; 23(1 Suppl): S41–45
   Google Scholar
• Khongphatthanayothin A, Wong PC, Samara Y, et al. Impact of respiratory syncytial virus infection on surgery for congenital heart disease: postoperative course and outcome. Crit Care Med1999; 27(9): 1974–1981
   Google Scholar
• Altman CA, Englund JA, Dem mler G, Drescher KL, Alexander MA. Respiratory syncytial virus in patients with congenital heart disease: a contemporary look at epidemiology and success of preoperative screening. Pediatr Card/al 2000; 21(5): 433–438
   Google Scholar
• Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection - a systematic review. Crit Care 2006; 10(4): R107
   Google Scholar
• Groothuis JR, Simoes EA, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 1993; 329(21): 1524–1530
   Google Scholar
• Respiratory Syncytial Virus. American Academy of Pediatrics. Red Book 2006:560–566
   Google Scholar
• Simoes EAF, Carbonell X-C, Losonsky G, Hultquist M, Harris B, Connor E, and the Motavizumab Study Group.. Phase III Trial of Motavizumab, an Enhanced Potency RSV Specific Monoclonal Antibody for the Prevention of Serious RSV Disease in High-Risk Infants. Abstract: 48th annual meeting of the European Society for Pediatric Research, Prague, 5–8 Oct 2007
   Google Scholar